|
Post by slugworth008 on Nov 9, 2017 19:29:27 GMT -5
@l27 11/9/17, 3:18 PM $MNKD saw another Afrezza ad on DR Phil show today in winston salem nc on abc ch 7 Dr. Phil took a puff of Afrezza and his hair grew back - friggen amazing! lol - Sorry I'm a bit punchy today Sports.
|
|
|
Post by dreamboatcruise on Nov 10, 2017 1:18:12 GMT -5
That is very disappointing to hear they aren't immediately starting the process for new commercial. To me the existing commercial at best hints at fast onset, though I think many would miss that, perhaps assuming it was just an inhaling convenience thing, and certainly it doesn't address the benefit of quick clearance. If I were management to save money I'd edit out enough of the existing one to splice in a quick shot of the new approved pd table with voice over that it is fastest onset and clearance of any mealtime. That couldn't cost a lot given no new live action or even animation. I disagree that they should work on a new commercial this time. They should air what they have while working on adding the additional 140mil shares. The commercial catches the attention of PWD which is what matters. Those PWD interested will go to the afrezza website which displays the new FDA label change right on the main page which is a brilliant move. Mike has experience in the field commercializing a FDA drug and that is why they bumped Matt. Mike knows where we are headed and many of us continue to be short sighted. Best of luck to all. Well, he's adjusted guidance to the lower end of where he thought they were going. If he makes it I'll give him credit, but scripts are going to have to start going up sharply in the very near future, or we'll not hit even that low end of the original range.
|
|
|
Post by sportsrancho on Nov 10, 2017 6:43:39 GMT -5
@dbuc1 11/9/17, 8:53 PM $MNKD So am I the only one here that saw the Afrezza commercial earlier on Thurs night football? Nashville
|
|
|
Post by mydogskip on Nov 10, 2017 7:32:39 GMT -5
@dbuc1 11/9/17, 8:53 PM $MNKD So am I the only one here that saw the Afrezza commercial earlier on Thurs night football? Nashville Running commercials in select areas and demographics is the smart way to do this unlike running a Superbowl ad as some have foolishly suggested. Results won't be immediate as we all know it takes time to see a doctor, let alone one that even knows about Afrezza. Mannkind is still trying to bush a boulder up a hill. As always, time will tell if how this ad campaign works now that the new label is in place.
|
|
|
Post by mydogskip on Nov 10, 2017 7:35:25 GMT -5
One of the reasons this commercial is so effective, IMO, is that it presents a step-by-step presentation of how to use Cologuard. I hope MannKind does something similar with its next Afrezza commercial.
1. Determine how many units of mealtime insulin you need based on what you're eating 2. Select the correct Afrezza cartridge (visual) 3. Load cartridge and inhale (click, snap, inhale)
The commercial currently being aired does show two people inhaling, but showing these steps will demonstrate how easy and simple this mealtime insulin is to use. Viewers will remember it.
Joke alert for those snowflakes with no sense of humor One thing is for sure, Mannkind investors know all about taking it up the colon due to the poor long term performance of the stock.
|
|
|
Post by epc1355 on Nov 10, 2017 7:40:14 GMT -5
Does anyone know what areas they are airing the commercial? Haven't seen anything in Chicago yet.....but I don't watch much TV. Also, how many Vdex sites are there? Where are those located? How long does it take to get in there? I think the effects of the commercial will be relatively slow in general (wait time to get in to endos, skeptical endos that will take time to see how well it works before converting more patients over). But there may be a small early bump if patients see the commercial and start heading into supporting clinics like Vdex!! How do I open a Vdex in Chicago?! Fingers crossed we don't have to wait 6 months to start seeing the benefit!!
|
|
|
Post by epc1355 on Nov 10, 2017 7:47:08 GMT -5
Does anyone know what areas they are airing the commercial? Haven't seen anything in Chicago yet.....but I don't watch much TV. Also, how many Vdex sites are there? Where are those located? How long does it take to get in there? I think the effects of the commercial will be relatively slow in general (wait time to get in to endos, skeptical endos that will take time to see how well it works before converting more patients over). But there may be a small early bump if patients see the commercial and start heading into supporting clinics like Vdex!! How do I open a Vdex in Chicago?! Fingers crossed we don't have to wait 6 months to start seeing the benefit!! Never mind re: Vdex. Just found all the answers on their website. And they are willing to help people open their own site!! Any investors or endocrinologists in Chicago want to join me?!
|
|
|
Post by mnholdem on Nov 10, 2017 8:17:54 GMT -5
@dbuc1 11/9/17, 8:53 PM $MNKD So am I the only one here that saw the Afrezza commercial earlier on Thurs night football? Nashville Running commercials in select areas and demographics is the smart way to do this unlike running a Superbowl ad as some have foolishly suggested. Results won't be immediate as we all know it takes time to see a doctor, let alone one that even knows about Afrezza. Mannkind is still trying to bush a boulder up a hill. As always, time will tell if how this ad campaign works now that the new label is in place. mnkd.proboards.com/thread/3729/formulary-tracker-plan-coverage-afrezza
Tennessee happens to have among the best coverage for Afrezza. Of its 317 commercial healthcare plans, Formulary Lookup reports 54% of Lives insured by these plans have Unrestricted Access for Afrezza plus an additional 10% cover Afrezza with restrictions.
If you look at the Commercial Table (see link above) you'll note that states with the highest % lives with unrestricted access (UA) to Afrezza or where Afrezza is covered with restrictions (CR) are:
- Maryland 56% UA + 14% CR = 70% of Lives in 299 plans
- Tennessee 54% UA + 10% CR = 64% of Lives in 317 plans
- Vermont 53% UA + 19% CR = 72% of Lives 186 plans
- Massachusetts 48% UA + 17% CR = 65% of Lives in 275 plans
- Idaho 48% UA + 37% CR = 85% of Lives in 216 plans
- New York 41% UA + 18% CR = 59% of Lives in 565 plans
- California 19% UA + 38% CR = 57% of Lives in 542 plans
It makes sense to me that if you're going to launch a TV campaign in targeted markets, you would go for the states that have the highest % lives covered by insurers. It makes sense that Tennessee is one those states targeted for Afrezza TV commercials. Insurance coverage is a huge roadblock in the path to exponential sales growth and MannKind would be prudent to target areas with the fewest obstacles.
|
|
|
Post by kball on Nov 10, 2017 8:26:08 GMT -5
On the other hand though, 60% of a state with a few million people vs a smaller % of folks of a state with 15+ million may tilt the targeting decision
|
|
|
Post by uvula on Nov 10, 2017 8:28:38 GMT -5
On the other hand though, 60% of a state with a few million people vs a smaller % of folks of a state with 15+ million may tilt the targeting decision The commercial in the larger market will cost more. That's got to be a factor also
|
|
|
Post by boytroy88 on Nov 10, 2017 8:28:44 GMT -5
On the other hand though, 60% of a state with a few million people vs a smaller % of folks of a state with 15+ million may tilt the targeting decision I was thinking the same thing.
|
|
|
Post by peppy on Nov 10, 2017 8:30:20 GMT -5
somewhere in the conference call, "California and New York state will be targeted", secondary to population and % of lives contracted/or PA.
|
|
|
Post by kball on Nov 10, 2017 8:35:58 GMT -5
Running commercials in select areas and demographics is the smart way to do this unlike running a Superbowl ad as some have foolishly suggested. Results won't be immediate as we all know it takes time to see a doctor, let alone one that even knows about Afrezza. Mannkind is still trying to bush a boulder up a hill. As always, time will tell if how this ad campaign works now that the new label is in place. mnkd.proboards.com/thread/3729/formulary-tracker-plan-coverage-afrezza
Tennessee happens to have among the best coverage for Afrezza. Of its 317 commercial healthcare plans, Formulary Lookup reports 54% of Lives insured by these plans have Unrestricted Access for Afrezza plus an additional 10% cover Afrezza with restrictions.
If you look at the Commercial Table (see link above) you'll note that states with the highest % lives with unrestricted access (UA) to Afrezza or where Afrezza is covered with restrictions (CR) are:
- Maryland 56% UA + 14% CR = 70% of Lives in 299 plans (6 million total pop)
- Tennessee 54% UA + 10% CR = 64% of Lives in 317 plans (7 million)
- Vermont 53% UA + 19% CR = 72% of Lives 186 plans (< 1 million)
- Massachusetts 48% UA + 17% CR = 65% of Lives in 275 plans (7 million)
- Idaho 48% UA + 37% CR = 85% of Lives in 216 plans(< 2 million)
- New York 41% UA + 18% CR = 59% of Lives in 565 plans (20 million)
- California 19% UA + 38% CR = 57% of Lives in 542 plans (40 million)
It makes sense to me that if you're going to launch a TV campaign in targeted markets, you would go for the states that have the highest % lives covered by insurers. It makes sense that Tennessee is one those states targeted for Afrezza TV commercials. Insurance coverage is a huge roadblock in the path to exponential sales growth and MannKind would be prudent to target areas with the fewest obstacles.
Population figures according to Siri as of 2015
|
|
|
Post by mnholdem on Nov 10, 2017 8:51:29 GMT -5
California, with 19% Unrestricted Access + 38% Restricted access to commercial insurance coverage for Afrezza in a state with a 2015 population of 40 million means California is where the gold is at...and I'm not talking about the mineral.
There is a huge $$$ potential if the results from the STAT trial can convince payers to remove restrictions. This would apply to all states but, as PB members are pointing out in other threads, the ROI on several Afrezza Phase 4 trials coupled with the independent research trials could be significant.
Some results may be published short term (STAT, 2018) but probably none of the current trials will be as significant to shareholders as the FDA-mandated post-market pediatric trial, IMHO.
|
|
|
Post by golfeveryday on Nov 10, 2017 19:19:14 GMT -5
@dbuc1 11/9/17, 8:53 PM $MNKD So am I the only one here that saw the Afrezza commercial earlier on Thurs night football? Nashville good to know. will watch closer as I am also In that market.
|
|